刘新泳山东大学主页平台管理系统--中文主页

科学研究

暂无内容

论文成果 More>>

郑义. SARS-CoV-2 NSP5 and N protein counteract the RIG-I signaling pathway by suppressing the formation of stress granules. SIGNAL TRANSDUCTION AND TARGETED THERAPY, 7, 2022.
杨斐. Chiral Metal Nanoparticle Superlattices Enabled by Porphyrin-Based Supramolecular Structures. Angewandte Chemie - International Edition, 2021.
郑义. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) membrane (M) protein inhibits type I and III interferon production by targeting RIG-I/MDA-5 signaling. SIGNAL TRANSDUCTION AND TARGETED THERAPY, 5, 2021.
陈琳. Tetramethylpyrazine analogue CXC195 protects against cerebral ischemia/reperfusion-induced apoptosis through PI3K/Akt/GSK3β pathway in rats. Neurochem Int, 66, 27, 2021.
闫实. Tetramethylpyrazine Analogue CXC195 Ameliorates Cerebral Ischemia-reperfusion Injury by Regulating Endothelial Nitric Oxide Synthase Phosphorylation Via PI3K/Akt Signaling. NEUROCHEM RES, 40, 446, 2021.
展鹏. Structure-Based Bioisosterism Yields HIV-1 NNRTIs with Improved Drug-Resistance Profiles and Favorable Pharmacokinetic Properties. J Med Chem, 2021.

著作成果 More>>

科研项目 More>>

暂无内容

刘新泳

教授

性别：男

在职信息：在职

所在单位：药学院

入职时间： 1991-07-01

版权所有 ©山东大学　地址：中国山东省济南市山大南路27号　邮编：250100　
查号台：（86）-0531-88395114
值班电话：（86）-0531-88364731　建设维护：山东大学信息化工作办公室　　
技术支持qq群：820336447
访问量：手机版 English 登录山东大学

最后更新时间： ..